Home › Pancreatic Cancer › North Dakota
Pancreatic Cancer clinical trials in North Dakota
6 studies for Pancreatic Cancer are looking for participants at sites in North Dakota.
Cities in North Dakota
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
- Sanford Bismarck Medical Center, Bismarck
- Sanford South University Medical Center, Fargo
- Southpointe-Sanford Medical Center Fargo, Fargo
- and 3 more
RecruitingObservational study
Ages 50 to 75 · All sexes · Updated Sep 4, 2026 · NCT04239573Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
- Sanford Bismarck Medical Center, Bismarck
- Sanford Broadway Medical Center, Fargo
- Sanford Roger Maris Cancer Center, Fargo
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT06958328Integrated Cancer Repository for Cancer Research
- Essentia Health, Fargo
- Trinity Hospital Cancer Care Center, Minot
RecruitingObservational studyHealthy volunteers welcome
Ages 19 to 110 · All sexes · Updated Jun 29, 2026 · NCT02012699Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
- Essentia Health Cancer Center-South University Clinic, Fargo
- Essentia Health - Jamestown Clinic, Jamestown
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 22, 2026 · NCT06998940A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
- Ohio State University-Telemedicine, Bismarck
- Ohio State University-Telemedicine, Fargo
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Feb 17, 2026 · NCT06906562SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Fargo
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.